Currently serves as Founder and CEO of Thymmune Therapeutics
Previously served as Founding Chief Scientific Officer at Cellino Biotech
Received his Ph.D. from the University of Cambridge as an NIH-Oxford/Cambridge and Gates Scholar, and his M.D. from Columbia University
